Misfolded α-Synuclein in Cerebrospinal Fluid of Contact Sport Athletes

Mov Disord. 2023 Nov;38(11):2125-2131. doi: 10.1002/mds.29621. Epub 2023 Oct 4.

Abstract

Background: Misfolded α-synuclein in Parkinson's disease (PD) and dementia with Lewy bodies (DLB) can be detected using the real-time quaking-induced conversion (RT-QuIC) technique in cerebrospinal fluid (CSF).

Objectives: The objectives are (1) to examine misfolded CSF α-synuclein incidence, and (2) to compare clinical presentation, sports history, brain volumes, and RT-QuIC α-synuclein positivity in former athletes.

Methods: Thirty former athletes with magnetic resonance imaging, neuropsychological testing, and CSF analyzed for phosphorylated tau 181 (p-tau), total tau (t-tau), amyloid-β 42 (Aβ42), and neurofilament light chain (NfL). CSF α-synuclein was detected using RT-QuIC.

Results: Six (20%) former athletes were α-synuclein positive. α-Synuclein positive athletes were similar to α-synuclein negative athletes on demographics, sports history, clinical features, CSF p-tau, t-tau, Aβ42, and NfL; however, had lower grey matter volumes in the right inferior orbitofrontal, right anterior insula and right olfactory cortices.

Conclusions: α-Synuclein RT-QuIC analysis of CSF may be useful as a prodromal biofluid marker of PD and DLB. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Keywords: Parkinson's; athletes; concussion; α synuclein.

MeSH terms

  • Amyloid beta-Peptides / cerebrospinal fluid
  • Athletes
  • Biomarkers / cerebrospinal fluid
  • Humans
  • Lewy Body Disease* / cerebrospinal fluid
  • Parkinson Disease* / cerebrospinal fluid
  • alpha-Synuclein / cerebrospinal fluid
  • tau Proteins / cerebrospinal fluid

Substances

  • alpha-Synuclein
  • tau Proteins
  • Amyloid beta-Peptides
  • Biomarkers